Global Virus Filtration Market

The global Virus Filtrationmarket was valued at USD 2.01billion in 2016 and is projected to reach USD 5.66billionby 2025, growing at a CAGR of 12.29% from 2017 to 2025.
Virus filtration, which is considered a robust and effective virus clearance technology, is a common unit operation in the manufacture of biologicals. With growing Virus clearance market and demand of viral disease treatments, the viral filter market is expected to grow during forecast period.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Rapid Growth in R&D sector and discoveries
1.2 Increasing fund availability for Biopharmaceutical sector
1.3 Increasing Govt. Support
2. Market Restraints
2.1 Highly Consolidated Market

Market Segmentation:
1. By Application:
1.1 Medical Devices
1.2 Water Purification
1.3 Air Purification
1.4 Biologicals
1.4.1 Vaccines and Therapeutics
1.4.2 Blood and Blood Products
1.4.3 Cellular and Gene Therapy Products
1.4.4 Tissue and Tissue Products
1.4.5 Stem Cell Products

2. By Product:
2.1 Kits and Reagents
2.2 Filtration Systems
2.3 Services
2.4 Other Products

3. By End User:
3.1 Pharmaceutical & Biotechnology Companies
3.2 Contract Research Organizations
3.3 Academic Research Institutes
3.4 Medical Device Companies

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Merck Kgaa
2. General Electric Company
3. Thermo Fisher Scientific, Inc.
4. Lonza Group Ltd.
5. Pall Corporation
6. Charles River Laboratories International, Inc.
7. Sigma-Aldrich Corporation
8. Sartorius AG
9. Asahi Kasei Medical Co., Ltd.
10. Wuxi Pharmatech (Cayman) Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY:
Research study on the Virus Filtrationmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL VIRUS FILTRATION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL VIRUS FILTRATIONMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL VIRUS FILTRATION MARKET, BY APPLICATION
5.1 Medical Devices
5.2 Water Purification
5.3 Air Purification
5.4 Biologicals
5.4.1 Vaccines and Therapeutics
5.4.2 Blood and Blood Products
5.4.3 Cellular and Gene Therapy Products
5.4.4 Tissue and Tissue Products
5.4.5 Stem Cell Products

6 GLOBAL VIRUS FILTRATION MARKET, BY PRODUCT
6.1 Kits and Reagents
6.2 Filtration Systems
6.3 Services
6.4 Other Products

7 GLOBAL VIRUS FILTRATION MARKET, BY END USER
7.1 Pharmaceutical & Biotechnology Companies
7.2 Contract Research Organizations
7.3 Academic Research Institutes
7.4 Medical Device Companies

8 GLOBAL VIRUS FILTRATIONMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025

9 GLOBAL VIRUS FILTRATIONMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Merck Kgaa
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 General Electric Company
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Thermo Fisher Scientific, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Lonza Group Ltd.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Pall Corporation
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Charles River Laboratories International, Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Sigma-Aldrich Corporation
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Sartorius AG
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Asahi Kasei Medical Co., Ltd.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Wuxi Pharmatech (Cayman) Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports